۱ | Nanobody-enhanced split-luciferase technology for innovative detection of the liver cancer biomarker alpha-fetoprotein | Oliayi M., Emamzadeh R., Nazari M. | Biochemical Engineering Journal | 2024-9-1 |
۲ | Nanobody-enhanced split-luciferase technology for innovative detection of the liver cancer biomarker alpha-fetoprotein | Oliayi M., Emamzadeh R., Nazari M. | Biochemical Engineering Journal, | 2024-9-1 |
۳ | Uncovering the role of leucine 59 in Renilla luciferase stability and activity with error-prone PCR: Implications for protein engineering | Fanaei-kahrani, Z., Emamzadeh, R., Nazari, M. | Protein Expression and Purification | 2024-2-1 |
۴ | Enhancing protein delivery for tissue regeneration: Development of AGR2-loaded hydrogels with controlled release properties | Akbari, A., Emamzadeh, R., Nazari, M., Brandstetter, T., Rühe, J. | International Journal of Biological Macromolecules | 2024-2-1 |
۵ | Optimization of a recombinant BlaR-CTD protein formulation using the response surface methodology | Abdolvahab, M.H., Safari, M., Hasannejad, F., (...), Salimi, A., Nazari, M. | Journal of Biological Engineering | 2024-12-1 |
۶ | Development of a bioluminescent homogenous nanobody-based immunoassay for the detection of prostate-specific antigen (PSA) | Baghdadi, M.E., Emamzadeh, R., Nazari, M., Michelini, E. | Enzyme and Microbial Technology | 2024-10-1 |
۷ | Development of a bioluminescent homogenous nanobody-based immunoassay for the detection of prostate-specific antigen (PSA) | ME Baghdadi, R Emamzadeh, M Nazari, E Michelini | Enzyme and Microbial Technology | 2024-0804 |
۸ | Exploring the Potential of Arginine to Increase Coelenterazine-Renilla Luciferase Affinity and Enzyme Stability: Kinetic and Molecular Dynamics Studies | Salehian, M., Emamzadeh, R., Nazari, M. | Protein Journal, | 2024 |
۹ | Tri-part NanoLuc as a new split technology with potential applications in chemical biology: a mini-review | Oliayi, M., Emamzadeh, R., Rastegar, M., Nazari, M. | Analytical Methods, | 2023-8-17 |
۱۰ | Structural studies and cell proliferation activity of human Follistatin-like 1 in reducing and non-reducing conditions | Shahrbanoo Jafari, S., Emamzadeh, R., Nazari, M., Ganjalikhany, M.R. | Process Biochemistry | 2023-7-1 |
۱۱ | Chitosan nanoparticle loaded by epidermal growth factor as a potential protein carrier for wound healing: In vitro and in vivo studies | Montazeri, S., Rastegari, A., Mohammadi, Z., (...), Najafzadeh, S., Aghsami, M. | IET Nanobiotechnology | 2023-5-1 |
۱۲ | Rescuing fertility during COVID-19 infection: exploring potential pharmacological and natural therapeutic approaches for comorbidity, by focusing on NLRP3 inflammasome mechanism | Hosseini, E., Kohan-Ghadr, H.-R., Bazrafkan, M., (...), Esfandyari, S., Nazari, M. | Journal of Assisted Reproduction and Genetics | 2023 |
۱۳ | Anti-tumor and anti-metastatic activity of the FGF2 118-126 fragment dependent on the loop structure | Allahmoradi, H., Asghari, S.M., Ahmadi, A., Assareh, E., Nazari, M. | Biochemical Journal | 2022-6-1 |
۱۴ | New Generation Vaccines for COVID-19 Based on Peptide, Viral Vector, Artificial Antigen Presenting Cell, DNA or mRNA | Rezaei, M., Nazari, M. | Avicenna Journal of Medical Biotechnology | 2022-3-1 |
۱۵ | Optimization of Expression and Purification of Recombinant Mouse plac1 | Rahdan, S., Razavi, S.A., Nazari, M., (...), Ramezani, A., Zarnani, A.-H. | Avicenna Journal of Medical Biotechnology | 2022-3-1 |
۱۶ | A recombinant affitoxin derived from a HER3 affibody and diphteria-toxin has potent and selective antitumor activity | Nazari, M., Emamzadeh, R., Jahanpanah, M., Yazdani, E., Radmanesh, R. | International Journal of Biological Macromolecules | 2022-10-31 |
۱۷ | Recombinant CD137-Fc, its synthesis, and applications for improving the immune system functions, such as tumor immunotherapy and to reduce the inflammation due to the novel coronavirus | Ajami, M., Nazari, M., mahmoodzadeh, H., Moazzeni, S.M. | Journal of Cellular Biochemistry | 2021-9-1 |
۱۸ | Zher2 affibody as a good candidate for detection of metastatic prostate cancer | Nazari, M., Radmanesh, R | Avicenna Journal of Medical Biotechnology | 2021-9-1 |
۱۹ | NLRP3 inflammasome: A joint, potential therapeutic target in management of COVID-19 and fertility problems | Bazrafkan, M., Hosseini, E., Nazari, M., Amorim, C.A., Sadeghi, M.R. | Journal of Reproductive Immunology | 2021-11-1 |
۲۰ | Development of recombinant biomimetic nano-carrier for targeted gene transfer to HER3 positive breast cancer | Nazari, M., Minai-Tehrani, A., Mousavi, S., Zamani Koukhaloo, S., Emamzadeh, R. | International Journal of Biological Macromolecules | 2021-10-31 |